Table 1.
Clinical Characteristics of COVID-19 Inpatients
| Characteristic | Total (n = 182) |
|---|---|
| Age, median (IQR), years | 60 (46–69) |
| Age group, n (%), years | |
| ≥60 | 92 (50.5) |
| <60 | 90 (49.5) |
| Sex, n (%) | |
| Male | 117 (64.3) |
| Female | 65 (35.7) |
| Comorbidities, n (%) | |
| Any | 140 (76.9) |
| Hypertension | 87 (47.8) |
| Obesity | 83 (45.6) |
| Type 2 DM | 64 (35.2) |
| Chronic kidney disease | 57 (31.3) |
| Cardiovascular diseases | 52 (28.6) |
| Stroke | 13 (7.1) |
| No comorbidities | 42 (23.1) |
| Time from illness onset to hospital admission, median (IQR), days | 3 (2–5) |
| Duration of hospitalization, median (IQR), days | 13 (9–18) |
| <13 days | 88 (48.4) |
| ≥13 days | 94 (51.6) |
| Laboratory findings, median (IQR) | |
| Procalcitonin | 1.27 (0.67–4.39) |
| Days of PCT measurement | 6 (5–8) |
| Oxygen support (%) | |
| Nasal cannula | 57 (33.7) |
| Non-rebreathing mask | 40 (23.7) |
| Ventilator | 30 (17.8) |
| High-flow nasal cannula | 20 (11.8) |
| Without oxygen support | 18 (10.7) |
| Simple mask | 4 (2.4) |
| Antibiotics history, n (%) | |
| No | 112 (61.5) |
| Yes | 70 (38.5) |
| Outcome, n (%) | |
| Survivor | 94 (51.6) |
| Nonsurvivor | 88 (48.4) |
Abbreviations: COVID-19, coronavirus disease; IQR, interquartile range; PCT, procalcitonin; DM, diabetes mellitus.